CN1857584A - Hypertension treating Chinese medicine preparation - Google Patents
Hypertension treating Chinese medicine preparation Download PDFInfo
- Publication number
- CN1857584A CN1857584A CNA200610011485XA CN200610011485A CN1857584A CN 1857584 A CN1857584 A CN 1857584A CN A200610011485X A CNA200610011485X A CN A200610011485XA CN 200610011485 A CN200610011485 A CN 200610011485A CN 1857584 A CN1857584 A CN 1857584A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- herba
- medicine preparation
- portions
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 60
- 206010020772 Hypertension Diseases 0.000 title claims abstract description 38
- 238000002360 preparation method Methods 0.000 title claims abstract description 16
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 17
- 241000180649 Panax notoginseng Species 0.000 claims description 17
- 241000237636 Pheretima Species 0.000 claims description 17
- 239000000843 powder Substances 0.000 claims description 15
- 241000218236 Cannabis Species 0.000 claims description 14
- 241000628997 Flos Species 0.000 claims description 14
- 210000000582 semen Anatomy 0.000 claims description 14
- 239000002994 raw material Substances 0.000 claims description 10
- 241000605447 Anemarrhena Species 0.000 claims description 9
- 241001529553 Scoparia <angiosperm> Species 0.000 claims description 9
- 239000002775 capsule Substances 0.000 claims description 7
- 230000001631 hypertensive effect Effects 0.000 claims description 7
- 239000008187 granular material Substances 0.000 claims description 6
- 239000003826 tablet Substances 0.000 claims description 6
- -1 electuary Substances 0.000 claims description 5
- 229940023488 pill Drugs 0.000 claims description 5
- 239000006187 pill Substances 0.000 claims description 5
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- 239000002552 dosage form Substances 0.000 claims description 4
- 239000006189 buccal tablet Substances 0.000 claims description 2
- 229940046011 buccal tablet Drugs 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 24
- 210000004185 liver Anatomy 0.000 abstract description 24
- 210000003734 kidney Anatomy 0.000 abstract description 14
- 230000001737 promoting effect Effects 0.000 abstract description 6
- 230000036772 blood pressure Effects 0.000 abstract description 5
- 230000027939 micturition Effects 0.000 abstract description 3
- 230000006870 function Effects 0.000 abstract description 2
- 239000000463 material Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 244000035851 Chrysanthemum leucanthemum Species 0.000 abstract 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 abstract 1
- 241000208688 Eucommia Species 0.000 abstract 1
- 241000361919 Metaphire sieboldi Species 0.000 abstract 1
- 244000179560 Prunella vulgaris Species 0.000 abstract 1
- 230000001914 calming effect Effects 0.000 abstract 1
- 238000010926 purge Methods 0.000 abstract 1
- 235000008113 selfheal Nutrition 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 23
- 239000000796 flavoring agent Substances 0.000 description 16
- 235000019634 flavors Nutrition 0.000 description 16
- 210000004369 blood Anatomy 0.000 description 11
- 239000008280 blood Substances 0.000 description 11
- 208000002173 dizziness Diseases 0.000 description 11
- 208000002193 Pain Diseases 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 206010019233 Headaches Diseases 0.000 description 7
- 210000002784 stomach Anatomy 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 7
- 230000001154 acute effect Effects 0.000 description 6
- 231100000869 headache Toxicity 0.000 description 6
- 210000002216 heart Anatomy 0.000 description 6
- 230000001717 pathogenic effect Effects 0.000 description 6
- 208000006820 Arthralgia Diseases 0.000 description 5
- 206010010904 Convulsion Diseases 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000035487 diastolic blood pressure Effects 0.000 description 5
- 210000003205 muscle Anatomy 0.000 description 5
- 230000008961 swelling Effects 0.000 description 5
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010030113 Oedema Diseases 0.000 description 4
- 208000004880 Polyuria Diseases 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 210000000988 bone and bone Anatomy 0.000 description 4
- 230000007812 deficiency Effects 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000001035 drying Methods 0.000 description 4
- 210000000232 gallbladder Anatomy 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 206010040872 skin infection Diseases 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 210000003932 urinary bladder Anatomy 0.000 description 4
- 206010011224 Cough Diseases 0.000 description 3
- 208000004232 Enteritis Diseases 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 206010062717 Increased upper airway secretion Diseases 0.000 description 3
- 206010023126 Jaundice Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 206010037660 Pyrexia Diseases 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 210000001015 abdomen Anatomy 0.000 description 3
- 208000010668 atopic eczema Diseases 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 239000006196 drop Substances 0.000 description 3
- 208000001848 dysentery Diseases 0.000 description 3
- 206010013990 dysuria Diseases 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 201000007227 lymph node tuberculosis Diseases 0.000 description 3
- 230000014759 maintenance of location Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 210000000056 organ Anatomy 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- 208000026435 phlegm Diseases 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 238000005303 weighing Methods 0.000 description 3
- 206010063409 Acarodermatitis Diseases 0.000 description 2
- 201000000736 Amenorrhea Diseases 0.000 description 2
- 206010001928 Amenorrhoea Diseases 0.000 description 2
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 208000008035 Back Pain Diseases 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 206010007247 Carbuncle Diseases 0.000 description 2
- 206010008190 Cerebrovascular accident Diseases 0.000 description 2
- 206010010726 Conjunctival oedema Diseases 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 241000201295 Euphrasia Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- 206010018498 Goitre Diseases 0.000 description 2
- 206010019468 Hemiplegia Diseases 0.000 description 2
- 208000037319 Hepatitis infectious Diseases 0.000 description 2
- 206010020741 Hyperpyrexia Diseases 0.000 description 2
- 206010021118 Hypotonia Diseases 0.000 description 2
- 208000019255 Menstrual disease Diseases 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 206010030302 Oliguria Diseases 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000031481 Pathologic Constriction Diseases 0.000 description 2
- 201000007100 Pharyngitis Diseases 0.000 description 2
- 241000447727 Scabies Species 0.000 description 2
- 208000006011 Stroke Diseases 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- 208000009205 Tinnitus Diseases 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 206010046788 Uterine haemorrhage Diseases 0.000 description 2
- 206010046910 Vaginal haemorrhage Diseases 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 231100000540 amenorrhea Toxicity 0.000 description 2
- 210000001367 artery Anatomy 0.000 description 2
- 208000006673 asthma Diseases 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 210000004556 brain Anatomy 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 206010006451 bronchitis Diseases 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000004069 differentiation Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 230000001882 diuretic effect Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 208000001780 epistaxis Diseases 0.000 description 2
- 208000017561 flaccidity Diseases 0.000 description 2
- 201000003872 goiter Diseases 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 208000005252 hepatitis A Diseases 0.000 description 2
- 241000411851 herbal medicine Species 0.000 description 2
- 210000000936 intestine Anatomy 0.000 description 2
- 210000002429 large intestine Anatomy 0.000 description 2
- 210000003141 lower extremity Anatomy 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 201000004792 malaria Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- 230000035935 pregnancy Effects 0.000 description 2
- 208000005687 scabies Diseases 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 230000036262 stenosis Effects 0.000 description 2
- 208000037804 stenosis Diseases 0.000 description 2
- 238000005728 strengthening Methods 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 231100000886 tinnitus Toxicity 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
- 206010000087 Abdominal pain upper Diseases 0.000 description 1
- 206010000358 Accelerated hypertension Diseases 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- 200000000007 Arterial disease Diseases 0.000 description 1
- 206010003175 Arterial spasm Diseases 0.000 description 1
- 206010003402 Arthropod sting Diseases 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 1
- 241000003910 Baronia <angiosperm> Species 0.000 description 1
- 201000006474 Brain Ischemia Diseases 0.000 description 1
- 206010006458 Bronchitis chronic Diseases 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 206010008120 Cerebral ischaemia Diseases 0.000 description 1
- 208000010445 Chilblains Diseases 0.000 description 1
- 206010009346 Clonus Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-AQKNRBDQSA-N D-glucopyranuronic acid Chemical compound OC1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-AQKNRBDQSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 208000005171 Dysmenorrhea Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000007530 Essential hypertension Diseases 0.000 description 1
- 208000015220 Febrile disease Diseases 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000005577 Gastroenteritis Diseases 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000034507 Haematemesis Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010019909 Hernia Diseases 0.000 description 1
- 208000031226 Hyperlipidaemia Diseases 0.000 description 1
- 208000015817 Infant Nutrition disease Diseases 0.000 description 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 206010024229 Leprosy Diseases 0.000 description 1
- 208000000501 Lipidoses Diseases 0.000 description 1
- 206010024585 Lipidosis Diseases 0.000 description 1
- 208000008930 Low Back Pain Diseases 0.000 description 1
- 206010026749 Mania Diseases 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 208000007443 Neurasthenia Diseases 0.000 description 1
- 241001597008 Nomeidae Species 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000721454 Pemphigus Species 0.000 description 1
- 206010034960 Photophobia Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 208000028017 Psychotic disease Diseases 0.000 description 1
- 206010067171 Regurgitation Diseases 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010043458 Thirst Diseases 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 208000002474 Tinea Diseases 0.000 description 1
- 241000130764 Tinea Species 0.000 description 1
- 206010053476 Traumatic haemorrhage Diseases 0.000 description 1
- 206010047601 Vitamin B1 deficiency Diseases 0.000 description 1
- 206010047631 Vitamin E deficiency Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031971 Yin Deficiency Diseases 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940072056 alginate Drugs 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 201000009961 allergic asthma Diseases 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 229940024606 amino acid Drugs 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 230000000507 anthelmentic effect Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 208000019804 backache Diseases 0.000 description 1
- 239000003659 bee venom Substances 0.000 description 1
- 208000002894 beriberi Diseases 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 229940119577 blood stop Drugs 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical compound [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 210000001627 cerebral artery Anatomy 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 201000001352 cholecystitis Diseases 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- 208000007451 chronic bronchitis Diseases 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 229940121657 clinical drug Drugs 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 201000003146 cystitis Diseases 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- FPAFDBFIGPHWGO-UHFFFAOYSA-N dioxosilane;oxomagnesium;hydrate Chemical compound O.[Mg]=O.[Mg]=O.[Mg]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O FPAFDBFIGPHWGO-UHFFFAOYSA-N 0.000 description 1
- 206010013023 diphtheria Diseases 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 229940124567 diuretic antihypertensive agent Drugs 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000007937 eating Effects 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008451 emotion Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 208000024756 faint Diseases 0.000 description 1
- 230000001605 fetal effect Effects 0.000 description 1
- 239000007941 film coated tablet Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 229940097043 glucuronic acid Drugs 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000007902 hard capsule Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 208000006750 hematuria Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 208000013403 hyperactivity Diseases 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 208000030603 inherited susceptibility to asthma Diseases 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 208000013433 lightheadedness Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 206010025482 malaise Diseases 0.000 description 1
- 201000005857 malignant hypertension Diseases 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000001617 migratory effect Effects 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 230000008816 organ damage Effects 0.000 description 1
- 230000004768 organ dysfunction Effects 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 230000008506 pathogenesis Effects 0.000 description 1
- 230000007170 pathology Effects 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- RLLPVAHGXHCWKJ-UHFFFAOYSA-N permethrin Chemical compound CC1(C)C(C=C(Cl)Cl)C1C(=O)OCC1=CC=CC(OC=2C=CC=CC=2)=C1 RLLPVAHGXHCWKJ-UHFFFAOYSA-N 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 235000002378 plant sterols Nutrition 0.000 description 1
- 210000002381 plasma Anatomy 0.000 description 1
- 239000011505 plaster Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 210000002254 renal artery Anatomy 0.000 description 1
- 210000001525 retina Anatomy 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039083 rhinitis Diseases 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 150000003376 silicon Chemical class 0.000 description 1
- 210000000329 smooth muscle myocyte Anatomy 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000007940 sugar coated tablet Substances 0.000 description 1
- 238000009495 sugar coating Methods 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 206010042772 syncope Diseases 0.000 description 1
- 230000009885 systemic effect Effects 0.000 description 1
- 230000004873 systolic arterial blood pressure Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 201000008827 tuberculosis Diseases 0.000 description 1
- 210000001113 umbilicus Anatomy 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Abstract
The hypertension treating Chinese medicine preparation is prepared with kendir, earthworm, wild chrysanthemum flower, selfheal, eucommia bark and other ten kinds of Chinese medicinal materials. It has the functions of clearing away heat, purging fire, calming liver and wind, nourishing Yin, benefiting kidney, promoting urination and lowering blood pressure. It is used in treating hypertension, and has determined curative effect, no toxic side effect, taking convenience and low cost.
Description
Technical field
The present invention relates to the hypertensive Chinese medicine preparation of a kind of treatment, is that a kind of hypertension for the treatment of is the Chinese medicine preparation of raw material with the Chinese herbal medicine.Belong to the field of Chinese medicines.
Background technology
Hypertension be meant systolic arterial pressure and (or) diastolic pressure increases, and is normal with organ dysfunction or the organic systemic diseases of changing into feature such as the heart, brain, kidney and retinas, the hypertension of not illustrating fully as yet for reason so far is called essential hypertension.Hypertension is one of modal cardiovascular diseases, and hypertensive prevalence is made a definite diagnosis by China more than 20 years old be 5.896, and borderline hypertension is 3.3%, and adding up to the hypertension prevalence of being grown up more than 20 years old is 9.1%.Estimate China hyperpietic up to more than 6,000 ten thousand, and have and increase trend year by year.Hypertension not only makes evidence of coronary heart diseases be multiplied, and is to cause cerebrovascular accident, reaches the major reason of the heart, renal function injury.
According to the clinical manifestation of hypertension, Chinese medicine mainly is familiar with its etiology and pathogenesis by dizzy, headache.Commonly encountered diseases is because of there being the following aspects: disorder of emotion, and eating and drinking without temperance, the prolonged illness overwork, natural endowment is unusual.Under the effect of the above-mentioned cause of disease, the imbalance between YIN and YANG of body, internal organs, meridians, QI and blood dysfunction, just having formed is the hypertension of main performance with the dizziness headache.Clinically often be divided into: excessive rising of liver-YANG, the hepatic and renal YIN deficiency, stagnation of phlegm-damp in middle-JIAO, obstruction of collaterals by blood stasis, type Coryza Treated by Syndrome Differentiation such as deficiency of both YIN and YANG.Doctor trained in Western medicine is thought the etiology unknown of hypertension, long-term psychentonia and lack physical work, and family history of hypertension, overweight, the salt amount is too much in the diet, a large amount of smokers, its prevalence is higher.Hypertension pathology: the initial stage only is the tiny arteriospasm of whole body, does not have obvious pathomorphism and changes.Secular hypertension is hardened the tiny tremulous pulse of whole body, and transparent sample changes under the inner membrance, and tube wall thickens, the elastic fiber hyperplasia of petty action astillen, and the plump hardening in middle level, luminal stenosis, the most remarkable with the tiny arterial disease of kidney.In medium and large artery trunks, the inner membrance lipidosis be can occur, atheromatous plaque, thrombosis etc. formed.Be mainly in coronary artery, cerebral arteries, renal artery, artery of lower extremity.The accelerated hypertension disease claims the malignant hypertension disease again, at the tiny arterial wall with a plurality of organs such as kidneys fibrinoid necrosis is arranged, the smooth muscle fiber fracture, blood plasma and erythrocyte are exuded in the arterial wall, finally to luminal stenosis even obstruction, so that PRF, the state of an illness worsens rapidly.
Hypertension is one of contemporary modal disease, and people's life and health in serious threat, becomes difficult problem that needs to be resolved hurrily of medical circle.Though western medicine controlling blood pressure effectively raises, can not improve symptom ideally, reverse target organ damage.Though Chinese medicine is not ideal enough aspect instant efficacy of antihypertensive treatment, is improving symptom and the aspects such as protective effect of target organs such as the heart, brain, kidney are had certain advantage.
Summary of the invention
The present invention develops in conjunction with the latest modern technological scientific achievement on the basis of traditional tcm syndrome differentiation and treatment.
The purpose of this invention is to provide a kind of determined curative effect, safe ready, little, the cheap pure Chinese medicine of side effect.
The present invention is made by the following weight proportion raw material:
5～15 parts of 3～7 parts of Flos Chrysanthemi Indicis of 10～30 parts of Pheretimas of Herba Apocyni veneti
5～15 parts of 3～7 parts of Herba Taxilli of 10～30 parts of Cortexs Eucommiae of Spica Prunellae
3～7 parts of 3～7 parts of Fructus Cannabiss of 10～30 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
3～7 parts of 3～7 portions of Herba Artemisiae Scopariaes of 3～7 parts of Rhizoma Anemarrhenaes of Radix Gentianae
3～7 parts of 3～7 portions of Radix Notoginseng are picked up on 3～7 parts of mountains of Semen Plantaginis with the fingers
The weight proportion of each raw material of optimization formula of the present invention is:
8～12 parts of 4～6 parts of Flos Chrysanthemi Indicis of 15～25 parts of Pheretimas of Herba Apocyni veneti
8～12 parts of 4～6 parts of Herba Taxillis of 15～25 parts of Cortexs Eucommiae of Spica Prunellae
4～6 parts of 4～6 parts of Fructus Cannabiss of 15～25 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
4～6 parts of 4～6 portions of Herba Artemisiae Scopariaes of 4～6 parts of Rhizoma Anemarrhenaes of Radix Gentianae
4～6 parts of 4～6 portions of Radix Notoginseng are picked up on 4～6 parts of mountains of Semen Plantaginis with the fingers
The weight proportion of each raw material of optimum formula of the present invention is:
10 parts of 5 parts of Flos Chrysanthemi Indicis of 20 parts of Pheretimas of Herba Apocyni veneti
10 parts of 5 parts of Herba Taxillis of 20 parts of Cortexs Eucommiae of Spica Prunellae
5 parts of 5 parts of Fructus Cannabiss of 20 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
5 parts of 5 portions of Herba Artemisiae Scopariaes of 5 parts of Rhizoma Anemarrhenaes of Radix Gentianae
5 parts of 5 portions of Radix Notoginseng are picked up on 5 parts of mountains of Semen Plantaginis with the fingers
Drug action mechanism among the present invention is as follows:
The Herba Apocyni veneti nature and flavor are sweet, bitter, cool.Return Liver Channel.Have suppressing the hyperactive liver and calm the nerves, heat clearing away blood pressure lowering, heart tonifying diuretic effect.Cure mainly palpitation and insomnia, be used for dizziness due to hyperactivity of liver-YANG, edema oliguria, hypertension, heart disease, neurasthenia, hepatitis abdominal distention, nephritis edema, allergic asthma flu etc." Chinese medicine medicine for preventing pharmacology and application " the 807th page
The Pheretima nature and flavor are salty, cold.Go into liver, spleen, lung, urinary bladder channel.Have heat clearing away, suppressing the hyperactive liver, Zhichuan, collateral dredging diuretic effect.Cure mainly high fanatical dry, convulsion with spasms, headache due to pathogenic wind-heat, conjunctival congestion, apoplexy and hemiplegia, pant, sore throat, arthralgia, bleeding from the gum, urinary obstruction, scrofula, mumps, skin infection, hyperpyrexia, bronchial asthma, hypertension, psychosis, ulcer of the lower limb, eczema, erysipelas, burn and scald, fracture etc." Chinese medicine medicine for preventing pharmacology and application " the 522nd page
Flos Chrysanthemi Indici nature and flavor hardship, suffering, be slightly cold.Return liver, heart channel.Effect with wind and heat dispersing, subduing swelling and detoxicating.Can treat anemopyretic cold, pneumonia, diphtheria, gastroenteritis, hypertension, furuncle, carbuncle, aphtha, erysipelas, eczema pemphigus etc." Chinese medicine medicine for preventing pharmacology and application " the 1112nd page
Spica Prunellae nature and flavor hardship, suffering, cold.Return liver, gallbladder meridian.Have clearing away liver-fire, make eye bright, eliminating stagnation, repercussive effect.Can treat scrofula, goiter, acute mastitis, conjunctival congestion and swelling pain, photophobia shed tears, have a headache dizzy, thyromegaly, tuberculous lymphadenitis, cyclomastopathy, hypertension, pulmonary tuberculosis, acute icteric infectious hepatitis, metrorrhagia, leukorrhagia, bones and muscles pain etc." Chinese medicine medicine for preventing pharmacology and application " the 1001st page
Cortex Eucommiae nature and flavor are sweet, wet.Return liver, kidney channel.Has invigorating the liver and kidney, bone and muscle strengthening, antiabortive effect.Can treat hypertension and doublely suffer from a deficiency of the kidney, back ache, foot and knee flaccidity, dribbling urination, uncontrolled urination are itched, vaginal bleeding during pregnancy is desired to fall, have a dizzy spell, frequent fetal movement etc." Chinese medicine medicine for preventing pharmacology and application " the 623rd page
Herba Taxilli nature and flavor hardship, sweet, flat.Return liver, kidney channel.Have invigorating the liver and kidney, bone and muscle strengthening, remove rheumatism, the meridian dredging, beneficial blood, antiabortive effect.Can treat that soreness of waist and knee joint, muscles and bones flaccidity are weak, hemiplegia, beriberi, anemofrigid-damp arthralgia, vaginal bleeding during pregnancy metrorrhagia, lack of lactation after delivery, coronary heart disease, hypertension etc." Chinese medicine medicine for preventing pharmacology and application " the 1060th page
The Ramulus Uncariae Cum Uncis nature and flavor are sweet, cool.Return liver, heart channel.Has the heat clearing away suppressing the hyperactive liver, the effect of the arresting convulsion that relieves dizziness, high fever, infantile convulsions, epilepsy, etc.Can treat pediatric epilepsy scared, adult's blood pressure is higher, and is dizzy, dizzy, married woman's eclamposia." Chinese medicine voluminous dictionary " the 1670th page.
Rhizoma Chuanxiong nature and flavor suffering, perfume (or spice).Return liver, gallbladder, pericardium channel.Has blood-activating and qi-promoting, the effect of wind-expelling pain-stopping.Can treat menoxenia, the amenorrhea dysmenorrhea, difficult labour produces stasis of blood stop block pain, lump in the abdomen stomachache, the twinge of the breast side of body, arthralgia due to cold clonic spasm of the muscle, tumbling and swelling, headache due to pathogenic wind-heat, rheumatic arthralgia, skin infection swells and ache, placenta retention, cerebral ischemia, coronary heart disease, angina pectoris, atherosclerosis, hypertension, radiotherapy, leukopenia due to the chemotherapy, juvenile myopia, vitamin e deficiency, flu is dizzy, external plug nose treating malaria disease etc." Chinese medicine medicine for preventing pharmacology and application " the 171st page.
The Fructus Cannabis nature and flavor are sweet, flat.Return spleen, stomach, large intestine channel.Have and moisturize, laxation, treating stranguria, the effect of invigorating blood circulation.Can treat blood deficiency and depleted fluid, dryness of the intestine constipation, pyretic stranguria, migratory arthralgia, dysentery, menoxenia, scabies, tinea leprosy etc." Chinese medicine medicine for preventing pharmacology and application " the 342nd page.
Radix Gentianae nature and flavor hardship, cold.Return liver, gallbladder meridian.Have eliminating pathogen in the liver gallbladder fire, the clear part of the body cavity below the umbilicus, housing the bladder, kidneys and bowels is wet, relieving convulsion making eye bright, and the malaria protozoon is good for the stomach, the effect that protects the liver.Can treat that Liver Channel intenseness of heat, infantile convulsion are manic, encephalitis B, headache, conjunctival congestion, pharyngalgia, jaundice, hematodiarrhoea, the swollen skin infection of pain, scrotum swell and ache, pudendum pruritus due to damp pathogen, hypertension dizziness tinnitus, chest and hypochondrium, acute infectious hepatitis, cystitis, skin infection swell and ache etc." Chinese medicine medicine for preventing pharmacology and application " the 413rd page.
Rhizoma Anemarrhenae nature and flavor hardship, sweet, cold.Return lung, stomach, kidney channel.Has clearing away heat-fire, the effect of promoting the production of body fluid and moisturizing.Can treat that fever caused by exogenous pathogenic factors, hyperpyrexia excessive thirst, tuberculosis heating, cough due to lung-heat, osteopyrexia and fever, interior-heat are quenched one's thirst, the dryness of the intestine constipation, dysuria, diabetes etc." Chinese medicine medicine for preventing pharmacology and application " the 817th page.
Herba Artemisiae Scopariae nature and flavor hardship, Xin Liang, be slightly cold.Return spleen, stomach, liver and gall, urinary bladder channel.Have clearing away damp-heat, jaundice eliminating subcutaneous ulcer, blood circulation promoting and blood stasis dispelling, promote blood circulation let out poison, anthelmintic, stimulated hepatic cell regeneration, control exterior deficiency, perspiration arranged, the effect of blood pressure lowering.Can treat icterohepatitis, cholecystitis, cholelithiasis, biliary tract ascarid, epidemic febrile disease from the beginning of the feeling sick of alternate attack of chill and fever, summer-heat, vomiting, jaundice oliguria, eczema pruritus, dysuria, pruritus due to wind pathogen skin ulcer scabies etc." Chinese medicine medicine for preventing pharmacology and application " the 890th page.
The Semen Plantaginis nature and flavor are sweet, be slightly cold.Return liver, kidney, lung, small intestinal, urinary bladder channel.Has clearing away heat and promoting diuresis, eliminating dampness by diuresis antidiarrheal, liver heat removing and eyesight improving, the effect of removing heat from the lung and dissipating phlegm.Can treat the cough due to lung-heat, urinary system infection, calculus, gastritis edema, dysuria, enteritis, bacillary dysentery, acute icterohepatitisshock, bronchitis, acute eye conjunctivitis, stranguria with turbid discharge, leukorrhagia, hematuria, edema, hematodiarrhoea is had loose bowels, epistaxis, conjunctival congestion and swelling pain, sore throat tonsillitis, cough, skin ulcer etc." Chinese medicine medicine for preventing pharmacology and application " the 291st page.
The mountain is picked up nature and flavor acid, sweet, tepor with the fingers.Return spleen, stomach, Liver Channel.Effect with promoting digestion and invigorating the stomach, circulation of qi promoting dissipating blood stasis.Can treat hypertension, coronary heart disease and control that meat is long-pending, wine long-pending, dyspepsia, gastral cavilty distension, lump in the abdomen, phlegm retention, feeling of fullness, acid regurgitation, dysentery, hemorrhoidal hamorrhage, lumbago, hernia, blood stasis amenorrhea, produce exceed the time limit unlikely, the newborn food stagnation of children's and the infantile malnutrition skin ulcer is itched, dermatitis rhus, chilblain, skin skin ulcer, chronic bronchitis, hyperlipidemia, bacillary dysentery, enteritis, taeniasis etc. of occipital headache, stasis of blood resistance, trusted subordinate's twinge, lochiorrhea, menstruation." Chinese medicine medicine for preventing pharmacology and application " the 141st page.
Sweet, the little hardship of Radix Notoginseng nature and flavor, temperature.Return liver, stomach, large intestine channel.Has the dissipating blood stasis hemostasis, the effect of subduing swelling and relieving pain.Can treat haematemesis, hemoptysis, epistaxis, have blood in stool, dysentery, metrorrhagia, lump in the abdomen, puerperal blood faints, retention of lochia, traumatic hemorrhage, breast ventral spine pain, fall and pounce on blood stasis, carbuncle pain, acute pharyngolaryngitis, Light-headedness, tinnitus, coronary heart disease, angina pectoris, acute necrosis sections enteritis, venom, bee sting, rheumatic arthritis disease, hypertension etc." Chinese medicine medicine for preventing pharmacology and application " the 60th page.
The present invention follows the principles of formulating prescriptions of the traditional Chinese medical science " monarch ", with Herba Apocyni veneti, Flos Chrysanthemi Indici, Spica Prunellae, Ramulus Uncariae Cum Uncis and Radix Gentianae is monarch drug, Pheretima, the Cortex Eucommiae, Herba Taxilli, Semen Plantaginis and Herba Artemisiae Scopariae are ministerial drug, and pick up with the fingers on the Rhizoma Anemarrhenae, mountain, Radix Notoginseng, Fructus Cannabis and Rhizoma Chuanxiong are adjuvant.All medicine phases and common tool clearing away heat-fire, suppressing the hyperactive liver to relieve the wind syndrome, the nourishing YIN for benefiting the kidney, the effect of diuretic antihypertensive, treatment hypertension, determined curative effect has no side effect, and taking convenience is cheap.
Chinese medicine preparation of the present invention, can add the medicine acceptable carrier when being prepared into medicament, described medicine acceptable carrier can be: starch, sucrose, lactose, mannitol, silicon derivative, cellulose family and derivant thereof, alginate, gelatin, polyvinylpyrrolidone, glycerol, soil temperature 80, agar, calcium carbonate, calcium bicarbonate, surfactant, Polyethylene Glycol, cyclodextrin, beta-schardinger dextrin-, phospholipid material, Kaolin, Pulvis Talci, calcium stearate, magnesium stearate etc.
Chinese medicine preparation of the present invention can be any pharmaceutically useful dosage form, and these dosage forms comprise: tablet, sugar coated tablet, film coated tablet, enteric coated tablet, capsule, hard capsule, soft capsule, oral liquid, suck agent, granule, electuary, pill, powder, unguentum, sublimed preparation, suspensoid, powder, solution, injection, suppository, ointment, plaster, cream, spray, drop, patch.Preparation of the present invention, peroral dosage form preferably, as: tablet, capsule, oral agents, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.Preferred Chinese medicine preparation is capsule, tablet, granule.
Clinical drug of the present invention uses the result to show that following advantage is arranged:
1, the Chinese herbal medicine each component selected for use of the present invention meets the regulation of The Drug Administration Law of People's Republic of China, utilizes the comprehensive function treatment hypertension of the Chinese medicine of respectively distinguishing the flavor of, and does not have chemical sweeting agent, and is nontoxic to human body.Show that through animal acute toxicity experiment the animal of being tested does not see any toxic reaction, its main organs does not have tangible change yet, and mice is 45g crude drug/kg to the maximum tolerated dose of medicine of the present invention, is 160 times of clinical people's consumption, and safety of medicine is reliable.
2, the present invention need not decoct, no bitterness sense, rich in proteins in the medicine, glucose, glucuronic acid, volatile oil, pectin, fructose, organic acid, lecithin, vitamin, aminoacid, also contain various trace elements such as Saponin, plant sterol and calcium, be beneficial to absorption of human body, health invigorating, and taking convenience.
3, the present invention can effectively treat and control hypertension, higher healing rehabilitation efficacy is arranged for I phase and II phase hyperpietic, has improved its life quality and time greatly for III phase hyperpietic.
Further specify the present invention to hypertensive therapeutic effect below by the clinical practice example.
Hypertension curative effect determinate standard: 1, more than the produce effects diastolic pressure decline 10mmHg, and reach normal range; Though diastolic pressure is not reduced to normally but is descended more than the 20mmHg.2, effectively diastolic pressure descends not as good as 10mmHg, but has reached normal range; Diastolic pressure is the preceding 10～19mmHg that descends of treatment, but does not reach normal range; Systolic pressure is more than the preceding decline 30mmHg of treatment.Must possess wherein 1.3, invalidly do not reach above standard person.
The clinical observation on the therapeutic effect result is as follows:
Through clinical observation treatment hyperpietic 32 examples, male's 20 examples wherein, women's 12 examples.Be II phase hyperpietic.Take embodiment 1 capsule, each 2-10 grain, every day three to four times, eliminating cold for resuscitation water send down, and take half an hour ante cibum.One month is a course of treatment, take continuously three the course of treatment observe the curative effect.Produce effects 17 examples account for 5396, and effective 13 examples account for 41%, and invalid 2 examples account for 6%, total effective rate 94%.
The specific embodiment
Embodiment 1: capsule takes by weighing raw material by following proportioning:
10 parts of 5 parts of Flos Chrysanthemi Indicis of 20 parts of Pheretimas of Herba Apocyni veneti
10 parts of 5 parts of Herba Taxillis of 20 parts of Cortexs Eucommiae of Spica Prunellae
5 parts of 5 parts of Fructus Cannabiss of 20 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
5 parts of 5 portions of Herba Artemisiae Scopariaes of 5 parts of Rhizoma Anemarrhenaes of Radix Gentianae
5 parts of 5 portions of Radix Notoginseng are picked up on 5 parts of mountains of Semen Plantaginis with the fingers
Production method is to get Pheretima earlier, the Cortex Eucommiae and Radix Notoginseng clean dry are crushed to 120～200 order fine powders, get Herba Apocyni veneti again, Flos Chrysanthemi Indici, Spica Prunellae, Herba Taxilli, Ramulus Uncariae Cum Uncis, Rhizoma Chuanxiong, Fructus Cannabis, Radix Gentianae, the Rhizoma Anemarrhenae, Herba Artemisiae Scopariae, Semen Plantaginis and mountain are picked up with the fingers and are decocted with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, and reclaimed ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Pheretima, the Cortex Eucommiae and Radix Notoginseng fine powder mixing, drying is ground into fine powder, incapsulates.Adorn 0.3 gram for every, common half an hour ante cibum is oral, and eliminating cold for resuscitation water send down.One time 2～10, three to four times on the one.One month is a course of treatment.
Embodiment 2: tablet takes by weighing raw material by following proportioning:
10 parts of 5 parts of Flos Chrysanthemi Indicis of 20 parts of Pheretimas of Herba Apocyni veneti
10 parts of 5 parts of Herba Taxillis of 20 parts of Cortexs Eucommiae of Spica Prunellae
5 parts of 5 parts of Fructus Cannabiss of 20 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
5 parts of 5 portions of Herba Artemisiae Scopariaes of 5 parts of Rhizoma Anemarrhenaes of Radix Gentianae
5 parts of 5 portions of Radix Notoginseng are picked up on 5 parts of mountains of Semen Plantaginis with the fingers
Production method is to get Pheretima earlier, the Cortex Eucommiae and Radix Notoginseng clean dry are crushed to 120～200 order fine powders, get Herba Apocyni veneti again, Flos Chrysanthemi Indici, Spica Prunellae, Herba Taxilli, Ramulus Uncariae Cum Uncis, Rhizoma Chuanxiong, Fructus Cannabis, Radix Gentianae, the Rhizoma Anemarrhenae, Herba Artemisiae Scopariae, Semen Plantaginis and mountain are picked up with the fingers and are decocted with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10, adding ethanol makes clear paste contain the alcohol amount to reach 70%, left standstill 24 hours, and reclaimed ethanol, when 50 degree～55 are spent, be concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Pheretima, the Cortex Eucommiae and Radix Notoginseng fine powder mixing, drying is ground into fine powder, adds appropriate amount of starch, alcohol granulation, after the drying, add an amount of magnesium stearate, tabletting, sugar coating are promptly.Common half an hour ante cibum is oral, and eliminating cold for resuscitation water send down.One time 2～10, three to four times on the one.One month is a course of treatment.
Embodiment 3: granule takes by weighing raw material by following proportioning:
10 parts of 5 parts of Flos Chrysanthemi Indicis of 20 parts of Pheretimas of Herba Apocyni veneti
10 parts of 5 parts of Herba Taxillis of 20 parts of Cortexs Eucommiae of Spica Prunellae
5 parts of 5 parts of Fructus Cannabiss of 20 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
5 parts of 5 portions of Herba Artemisiae Scopariaes of 5 parts of Rhizoma Anemarrhenaes of Radix Gentianae
5 parts of 5 portions of Radix Notoginseng are picked up on 5 parts of mountains of Semen Plantaginis with the fingers
Production method is to get Pheretima earlier, the Cortex Eucommiae and Radix Notoginseng clean dry are crushed to 120～200 order fine powders, get Herba Apocyni veneti again, Flos Chrysanthemi Indici, Spica Prunellae, Herba Taxilli, Ramulus Uncariae Cum Uncis, Rhizoma Chuanxiong, Fructus Cannabis, Radix Gentianae, the Rhizoma Anemarrhenae, Herba Artemisiae Scopariae, Semen Plantaginis and mountain are picked up with the fingers and are decocted with water twice, 1.5～2 hours for the first time, 0.5～1 hour for the second time, merge decocting liquid twice, filter, filtrate is concentrated into 80 degree～85 when spending, the clear paste of relative density 1.08～1.10 adds ethanol and makes clear paste contain the alcohol amount to reach 7096, left standstill 24 hours, reclaim ethanol, when spending, 50 degree～55 are concentrated into the clear paste of relative density 1.30～1.32, again with clear paste and Pheretima, the Cortex Eucommiae and Radix Notoginseng fine powder mixing, drying, be ground into fine powder, add an amount of sucrose and soluble starch, alcohol granulation, the pack of dry back is promptly.Usually half an hour ante cibum warm boiled water, one time 1～3 bag, three to four times on the one.One month is a course of treatment.
Claims (6)
1, the hypertensive Chinese medicine preparation of a kind of treatment.It is characterized in that it is made by the following weight proportion raw material:
5～15 parts of 3～7 parts of Flos Chrysanthemi Indicis of 10～30 parts of Pheretimas of Herba Apocyni veneti
5～15 parts of 3～7 parts of Herba Taxillis of 10～30 parts of Cortexs Eucommiae of Spica Prunellae
3～7 parts of 3～7 parts of Fructus Cannabiss of 10～30 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
3～7 parts of 3～7 portions of Herba Artemisiae Scopariaes of 3～7 parts of Rhizoma Anemarrhenaes of Radix Gentianae
3～7 parts of 3～7 portions of Radix Notoginseng are picked up on 3～7 parts of mountains of Semen Plantaginis with the fingers
2, the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, wherein the weight proportion of each raw material is:
8～12 parts of 4～6 parts of Flos Chrysanthemi Indicis of 15～25 parts of Pheretimas of Herba Apocyni veneti
8～12 parts of 4～6 parts of Herba Taxillis of 15～25 parts of Cortexs Eucommiae of Spica Prunellae
4～6 parts of 4～6 parts of Fructus Cannabiss of 15～25 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
4～6 parts of 4～6 portions of Herba Artemisiae Scopariaes of 4～6 parts of Rhizoma Anemarrhenaes of Radix Gentianae
4～6 parts of 4～6 portions of Radix Notoginseng are picked up on 4～6 parts of mountains of Semen Plantaginis with the fingers
3, the hypertensive Chinese medicine preparation of a kind of treatment according to claim 1, wherein the weight proportion of each raw material is:
10 parts of 5 parts of Flos Chrysanthemi Indicis of 20 parts of Pheretimas of Herba Apocyni veneti
10 parts of 5 parts of Herba Taxillis of 20 parts of Cortexs Eucommiae of Spica Prunellae
5 parts of 5 parts of Fructus Cannabiss of 20 parts of Rhizoma Chuanxiongs of Ramulus Uncariae Cum Uncis
5 parts of 5 portions of Herba Artemisiae Scopariaes of 5 parts of Rhizoma Anemarrhenaes of Radix Gentianae
5 parts of 5 portions of Radix Notoginseng are picked up on 5 parts of mountains of Semen Plantaginis with the fingers
4, the Chinese medicine preparation of claim 1-3 is to be fit to medicinal various dosage forms.
5, the Chinese medicine preparation of claim 4 is tablet, capsule, oral agents, buccal tablet, granule, electuary, pill, powder, suspensoid, powder, solution, drop, drop pill.
6, the Chinese medicine preparation of claim 4 is capsule, tablet, granule.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610011485XA CN100473404C (en) | 2006-03-14 | 2006-03-14 | Hypertension treating Chinese medicine preparation |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB200610011485XA CN100473404C (en) | 2006-03-14 | 2006-03-14 | Hypertension treating Chinese medicine preparation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN1857584A true CN1857584A (en) | 2006-11-08 |
| CN100473404C CN100473404C (en) | 2009-04-01 |
Family
ID=37296572
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CNB200610011485XA Expired - Fee Related CN100473404C (en) | 2006-03-14 | 2006-03-14 | Hypertension treating Chinese medicine preparation |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN100473404C (en) |
Cited By (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100558378C (en) * | 2007-05-29 | 2009-11-11 | 沈信堂 | The hypertensive Chinese medicine of a kind of treatment |
| CN102614390A (en) * | 2012-05-01 | 2012-08-01 | 马守云 | Medicine for treating hypertension |
| CN102698124A (en) * | 2012-01-17 | 2012-10-03 | 李付德 | Traditional Chinese medicinal composition for treating yang-deficiency bipolar type systolic and diastolic hypertension |
| CN103006996A (en) * | 2012-12-31 | 2013-04-03 | 苗洁清 | Medicine for treating accelerated hypertension |
| WO2015018124A1 (en) * | 2013-08-09 | 2015-02-12 | Tian Yi Er | Traditional chinese medicine preparation for reducing blood pressure and preparation method thereof |
| CN104474342A (en) * | 2014-12-11 | 2015-04-01 | 胡波 | Tea cream for drinking of people with high blood pressure, high blood sugar and hyperlipidemia and preparation method of tea cream |
| CN105079586A (en) * | 2015-10-07 | 2015-11-25 | 青岛云天生物技术有限公司 | Traditional Chinese medicine composition for treating hypertension |
| CN105816699A (en) * | 2016-03-25 | 2016-08-03 | 广西大学 | Sparassis crispa healthcare oral liquid with lipid and pressure reducing effects and preparation method thereof |
| CN112493587A (en) * | 2020-12-18 | 2021-03-16 | 鲁南制药集团股份有限公司 | Separated anti-virus health mask |
-
2006
- 2006-03-14 CN CNB200610011485XA patent/CN100473404C/en not_active Expired - Fee Related
Cited By (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN100558378C (en) * | 2007-05-29 | 2009-11-11 | 沈信堂 | The hypertensive Chinese medicine of a kind of treatment |
| CN102698124A (en) * | 2012-01-17 | 2012-10-03 | 李付德 | Traditional Chinese medicinal composition for treating yang-deficiency bipolar type systolic and diastolic hypertension |
| CN102698124B (en) * | 2012-01-17 | 2013-11-06 | 李付德 | Traditional Chinese medicinal composition for treating yang-deficiency bipolar type systolic and diastolic hypertension |
| CN102614390A (en) * | 2012-05-01 | 2012-08-01 | 马守云 | Medicine for treating hypertension |
| CN103006996A (en) * | 2012-12-31 | 2013-04-03 | 苗洁清 | Medicine for treating accelerated hypertension |
| CN103006996B (en) * | 2012-12-31 | 2014-03-12 | 威海市妇女儿童医院 | Medicine for treating accelerated hypertension |
| WO2015018124A1 (en) * | 2013-08-09 | 2015-02-12 | Tian Yi Er | Traditional chinese medicine preparation for reducing blood pressure and preparation method thereof |
| CN104474342A (en) * | 2014-12-11 | 2015-04-01 | 胡波 | Tea cream for drinking of people with high blood pressure, high blood sugar and hyperlipidemia and preparation method of tea cream |
| CN105079586A (en) * | 2015-10-07 | 2015-11-25 | 青岛云天生物技术有限公司 | Traditional Chinese medicine composition for treating hypertension |
| CN105816699A (en) * | 2016-03-25 | 2016-08-03 | 广西大学 | Sparassis crispa healthcare oral liquid with lipid and pressure reducing effects and preparation method thereof |
| CN112493587A (en) * | 2020-12-18 | 2021-03-16 | 鲁南制药集团股份有限公司 | Separated anti-virus health mask |
Also Published As
| Publication number | Publication date |
|---|---|
| CN100473404C (en) | 2009-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN100473404C (en) | Hypertension treating Chinese medicine preparation | |
| CN1857666A (en) | Chinese medicine preparation for treating senile dementia | |
| CN103520680B (en) | The Chinese medicine for the treatment of acute heart failure | |
| CN1943745A (en) | A Chinese traditional medicinal preparation for treatment of urticaria | |
| CN103623244A (en) | Antihypertensive traditional Chinese medicine and preparation method therefor | |
| CN100431568C (en) | Chinese medicine for treating puerperal hypogalactia | |
| CN101032604A (en) | Chinese medicine preparation for curing vascular type headache | |
| CN1943741A (en) | A Chinese traditional medicinal preparation for treatment of eczema | |
| CN101028490A (en) | Chinese medicine for treating acne | |
| CN1958028A (en) | Preparation of Chinese traditional medicine for treating hyperplasia of prostate | |
| CN101028492A (en) | Chinese preparation for treating hysteromyoma | |
| CN101028421B (en) | Chinese medicine for treating chronic kidney failure | |
| CN104324314A (en) | Pharmaceutical composition for treating gastropathy | |
| CN106309900A (en) | Capsule medicine for treating coronary disease and angina and preparation method thereof | |
| CN101028445A (en) | Chinese medicine for treating ichthyosis | |
| CN101028352A (en) | Chinese-medicinal preparation for treating ischiodynia | |
| CN1256976C (en) | Anti-cancer Chinese medicinal composition and its preparing method | |
| CN105963619A (en) | Traditional Chinese medicine composition for treating uterus coldness infertility | |
| CN1966047A (en) | Chinese medicinal formulation for treating prostate hyperplasia | |
| CN1857533A (en) | Chinese medicine preparation for preventing and treating cerebral thrombus and its sequel | |
| CN105456933A (en) | Traditional Chinese medicine capable of activating blood to remove stasis and clearing and activating channels and collaterals and preparation method of traditional Chinese medicine | |
| CN106581386A (en) | Traditional Chinese medicine preparation capable of lowering blood pressure and preparation method thereof | |
| CN106581391A (en) | High blood pressure treating traditional Chinese medicine and production method thereof | |
| CN106606644A (en) | Traditional Chinese medicine for preparing hypertension and preparation method thereof | |
| CN106581388A (en) | High blood pressure prevention and treatment traditional Chinese medicine composition and production method thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| EE01 | Entry into force of recordation of patent licensing contract |
Assignee: Sichuan Horae Pharmaceutical Co., Ltd. Assignor: Wang Xinsuo Contract record no.: 2011510000270 Denomination of invention: Hypertension treating traditional Chinese medicine preparation and its preparing process Granted publication date: 20090401 License type: Exclusive License Open date: 20061108 Record date: 20110915 |
|
| ASS | Succession or assignment of patent right |
Owner name: CHEN YUTANG Free format text: FORMER OWNER: WANG XINSUO Effective date: 20120331 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Chen Yutang Inventor before: Wang Xinsuo |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100072 FENGTAI, BEIJING TO: 100076 DAXING, BEIJING Free format text: CORRECT: INVENTOR; FROM: WANG XINSUO TO: CHEN YUTANG |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20120331 Address after: 100076, Beijing, Xihongmen Town, fourth village, Minsheng Road, North East six, No. 10, Beijing Sino US joint innovation and Research Institute of international difficult diseases, Daxing District Patentee after: Chen Yutang Address before: 100072 Beijing Fengtai Changxindian Hospital Patentee before: Wang Xinsuo |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING SINO-US JOINT INTERNATIONAL DISEASES RESEA Free format text: FORMER OWNER: CHEN YUTANG Effective date: 20120417 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20120417 Address after: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing, Xihongmen Town, fourth village, Minsheng Road, North East six, No. 10, Beijing Sino US joint innovation and Research Institute of international difficult diseases, Daxing District Patentee before: Chen Yutang |
|
| ASS | Succession or assignment of patent right |
Owner name: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONA Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121015 Owner name: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATION Effective date: 20121015 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100076 DAXING, BEIJING TO: 100012 CHAOYANG, BEIJING |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121015 Address after: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee after: Beijing new China International Pharmaceutical Research Institute Patentee after: Beijing Sino US Joint Institute of innovation and international difficult diseases Address before: 100076, Beijing Daxing District Xihongmen town fourth village Minsheng Road North East six 10, Beijing Sino US Joint Innovation Institute of international difficult disease Chen Zhonghua Dean Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| ASS | Succession or assignment of patent right |
Free format text: FORMER OWNER: BEIJING SINA-AMERICA INNOVATION UNITED INTERNATIONAL DIFFICULT DISEASE RESEARCH INSTITUTE Effective date: 20121116 Owner name: BEIJING JINKUI CHINESE MEDICAL RESEARCH INSTITUTE Free format text: FORMER OWNER: BEIJING CHINESE AND FOREIGN XINCHUANG INTERNATIONAL MEDICAL RESEARCH INSTITUTE Effective date: 20121116 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Lin Wanshuo Inventor before: Chen Yutang |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100012 CHAOYANG, BEIJING TO: 100010 DONGCHENG, BEIJING Free format text: CORRECT: INVENTOR; FROM: CHEN YUTANG TO: LIN WANSHUO |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20121116 Address after: 100010, No. 3-1, building 3, Beijing Hutong, Dongcheng District, China Patentee after: Beijing Jingui Chinese Medicine Research Institute Co. Ltd. Address before: 100012 Beijing city Chaoyang District Shangli Road No. 201 Beijing Chinese New International Medical Research Institute Patentee before: Beijing new China International Pharmaceutical Research Institute Patentee before: Beijing Sino US Joint Institute of innovation and international difficult diseases |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20090401 Termination date: 20200314 |
|
| CF01 | Termination of patent right due to non-payment of annual fee |